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Abstract
Background: Much of the debate as to whether or not the scaling up of HIV service delivery in Africa benefits
non-HIV priority services has focused on the use of nationally aggregated data. This paper analyses and presents
routine health facility record data to show trend correlations across priority services.
Methods: Review of district office and health facility client records for 39 health facilities in three districts of
Zambia, covering four consecutive years (2004-07). Intra-facility analyses were conducted, service and coverage
trends assessed and rank correlations between services measured to compare service trends within facilities.
Results: VCT, ART and PMTCT client numbers and coverage levels increased rapidly. There were some strong
positive correlations in trends within facilities between reproductive health services (family planning and antenatal
care) and ART and PMTCT, with Spearman rank correlations ranging from 0.33 to 0.83. Childhood immunisation
coverage also increased. Stock-outs of important drugs for non-HIV priority services were significantly more
frequent than were stock-outs of antiretroviral drugs.
Conclusions: The analysis shows scale-up in reproductive health service numbers in the same facilities where HIV
services were scaling up. While district childhood immunisations increased overall, this did not necessarily occur in
facility catchment areas where HIV service scale-up occurred. The paper demonstrates an approach for comparing
correlation trends across different services, using routine health facility information. Larger samples and explanatory
studies are needed to understand the client, facility and health systems factors that contribute to positive and
negative synergies between priority services.
Background
Funding for HIV and AIDS control in Africa is heavily
reliant on a small number of donors, with external fund-
ing in 2006 estimated to have accounted for between 67%
and 81% of all AIDS funding in four African countries
[1]. Zambia was in the mid range at 74% donor-reliant.
Almost half (49%) of all external funding for HIV/AIDS
came from two global health initiatives (GHIs), which
specifically targeted HIV and AIDS [2]: The Global Fund
to Fight AIDS, Tuberculosis and Malaria and the United
States President’s Emergency Plan for AIDS Relief (PEP-
FAR). Globally, disbursements for HIV control grew
from just over 3% of development assistance for health in
1990 to 23% [3] or 47% in 2007 [4], depending on the
data source. While funding to HIV and AIDS has been
generally welcomed - and with unvarnished enthusiasm
by some - others have expressed concern about the possi-
ble effects of HIV/AIDS funding levels that reportedly
exceed the total amount allocated to the health sector in
some African countries [2,5,6].
Much of the debate has been around displacement
and crowding-out effects that spending on HIV and
AIDS might have on other health and development
priorities [4,6], with claims of negative effects through a
shift of funding away from health systems strengthening
[4,5]; and from other non-HIV/AIDS disease control
priorities [7,8]. Counter-claims that spending on HIV/
AIDS strengthens health systems have been made, often
by those who work in the field of HIV/AIDS control
[9,10]. Justification given for HIV spending is that HIV
disease over-burdens health facilities, crowds out care
for other conditions and the introduction of antire-
troviral treatment (ART) reduces the AIDS burden at
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gested whereby HIV funding would strengthen labora-
tory systems [12] and pharmacy management [13], and
lead to improvements in the delivery of other disease
control programmes. However, there is limited empirical
evidence on the impact of HIV scale-up on the routine
delivery of other priority services and “opinion rather
than evidence has dominated the debate” [14]. While
drafting this paper, we found one paper that reported
positive effects, whereby syphilis screening of pregnant
women increased significantly, in association with Pre-
vention of Mother to Child HIV Transmission
(PMTCT) scale-up [15].
Large amounts of Global Fund and PEPFAR money
were flowing into Zambia from 2004 and significant
scale-up of ART and PMTCT was taking place
[1,16,17]. We conducted a study to explore the health
systems effects of this scale-up, specifically in the area
of human resources for health (reported elsewhere) and
on other non-HIV priority service delivery and coverage.
This paper presents and discusses correlations in intra-
facility trends in client numbers and population cover-
age for a range of HIV and non-HIV priorities. It does
this by analysing retrospective health facility record
data, 2004-07, across a range of public and NGO health
facilities in Zambia. The paper aims to demonstrate the
utility of analysing routine health facility data, and pro-
poses further research that could explain service trends
and alert programme managers to areas that might
require responses.
Methods
Three districts were purposively selected for the study to
represent the capital city (Lusaka), an urban district
(Kabwe) and a rural district (Mumbwa). District health
facilities were mapped in 2007 and again in 2008 to
identify all fixed government and NGO facilities provid-
ing HIV or AIDS services (those providing outreach ser-
vices only and Ministry of Defence and private for-profit
facilities were excluded). Based on discussions with Dis-
trict Health Management Teams (DHMTs), 39 facilities
were selected for the survey (n = 33 government and
n = 6 NGO/mission). These included all 29 facilities
that reported delivering ART (24 government and 5
NGO/mission). The sample also included a purposive
sample of 10 facilities that were reported by the
DHMTs as important providers of HIV services, though
not ART (1 facility in Lusaka, 2 in Kabwe and 7 in
Mumbwa). All district, mission and central hospitals,
and the University Teaching Hospital (UTH) in Lusaka,
were included. Ethics approval for the study was granted
by the University of Zambia Research Ethics Committee.
Following a pilot survey, a trained and supervised
team of field workers extracted and recorded facility
record data in June-July 2008, including patient/client
and service episode records for complete years 2004-
2007 inclusive. The proformas used to record the facility
record data, which provide the basis for this paper, were
adapted based on lessons learned from a similar Febru-
ary 2007 facility survey. Non-HIV patient record data
that were collected from facilities were supplemented by
electronic summaries of facility record-return data kept
at district health offices. Where there were two sources
of data, the most complete data set was used in the ana-
lysis. For example, district offices supplied complete
data on family planning and antenatal clinic clients for
29 facilities from 2004 to 2007, compared to 21 facilities
whose records’ departments had complete data on
family planning and 19 on antenatal client registrations.
The most complete data held at district offices were for
reproductive health (family planning and antenatal care)
and childhood immunisations, which made them the
most useful data for estimating non-HIV performance.
HIV service data were not available from district offices
in Zambia and were collected directly from the facilities
that were delivering ART, Voluntary Counselling and
Testing (VCT) or PMTCT services.
Quantitative data were entered, cleaned and analysed
using SPSS (Version 16.0), with further analysis using
SAS (Version 9.1). Where facility data were missing for
one time period within a trend analysis, this facility was
omitted from the analysis, which reduced the numbers
of units in some analyses.
Results
Table 1 summarises the range of HIV related services
identified in the 2008 mapping exercise: all 39 health
facilities offered VCT services, almost all (37) provided
PMTCT, 29 provided ART; and most offered a wide
range of HIV support services. Of facilities that provided
HIV services, significantly fewer in rural Mumbwa -
5/11 (45%) - provided ART compared to the two urban
districts (p. < 0.01). Almost all (95%) of the facilities
provided condoms. All facilities in Lusaka provided fee
exemptions for people living with HIV/AIDS, compared
with 90% in Kabwe and 91% in Mumbwa. Similarly, the
provision of food and nutrition support was more wide-
spread in Lusaka (100%) than in the other two districts
and was significantly higher in urban than in rural facil-
ities (31% in Mumbwa, p < 0.01). Home based care was
provided by three quarters of facilities, with no signifi-
cant difference by district or urban/rural setting.
Figure 1 shows the trends and scale-up in the num-
bers of clients who registered for ART, PMTCT, VCT,
and the numbers of infants who received two important
vaccinations across 2004-07, based on facilities that
reported complete data across the four time periods.
Numbers of clients on ART increased from 8,843 in
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45,777; and PMTCT clients from 14,541 to 26,066 in
2007. ART clients registered at the 24 facilities included
in the analysis for this study constituted a sizable pro-
portion of the national figures reported by Zambia in its
2008 UN General Assembly on AIDS (UNGASS) report
[18]: 21,267 (54% of) clients reported nationally for
2005, 33,016 (41%) for 2006 and 44,311 (30%) of all
clients reported to be on ART in Zambia in 2007. The
high proportion of ART clients included in our study
that were reported nationally was because we surveyed
the main ART facilities in Lusaka, where scale-up
started earlier. As scale-up rolled out to towns in 2006
and rural areas in 2007, there was a reduction in the
proportion of clients receiving their ART in facilities in
the capital city, both in our study and nationally.
Children’s vaccinations (numbers of antigens given
and coverage levels) provide useful indicators of the per-
formance of non-HIV/AIDS services. Bacille Calmette
Guerin (BCG), which reduces the risk of serious TB
complications in children and is given as a long term
measure to reduce TB in the population, is a good indi-
cator of the number and proportion of infants starting
immunisations. DPT 3 (the third antigen or dose of the
3-in-1 vaccine for Diphtheria, Pertussis and Tetanus),
which requires that the child be vaccinated on three
separate occasions, is a good indicator of the perfor-
mance of the Expanded Programme of Immunisation.
The third dose is given ideally before six months of age.
T h em o s tc o m p l e t ei m m u n i s a t i o nd a t as e t st h a tw e r e
obtained from the DHMT were for BCG and DPT3,
where complete data from 2004 to 2007 were obtained
for 28 facilities (BCG) and 27 facilities (DPT3) delivering
mother and child health services. Figure 1 shows a
steady rise in the numbers of DPT 3 (31,290 to 44,311)
and BCG doses (49,261 to 56,107) delivered annually,
2004 to 2007.
Table 2 shows that average ART coverage levels across
the three districts increased steadily from 20% in 2004
to 75% in 2007 in the 16 facilities that had catchment
populations and that were reporting complete data from
2004 to 2007. Facilities with missing data or reporting
no ART provision across the four years were excluded
from the analysis. The graph and table show a correc-
tion for 2007, including ART coverage for 18 surveyed
facilities, including two additonal ones with catchment
populations that reported ART delivery in 2007 alone.
Coverage was estimated as follows: HIV prevalence esti-
mates reported annually for Lusaka province, Central
province urban (Kabwe) and rural (Mumbwa) were
Table 1 HIV and selected non-HIV services provided by district fixed facilities
All Districts
(n = 39)
Lusaka (urban)
(n = 18)
Kabwe (urban)
(n = 10)
Mumbwa (rural)
(n = 11)
Urban
(n = 28)
Rural
(n = 11)
Core HIV services
ART 29 16 8 5 24 5
VCT 39 18 10 11 28 11
PMTCT 37 16 10 11 26 11
HIV support services
Food/nutrition support for HIV+ people 27 18 5 4 23 4
Income Generating activities for HIV+ people 13 8 1 4 9 4
Fee exemptions for people infected with HIV+ 37 18 9 10 27 10
Information, Eductional and Communication materials 38 18 9 11 27 11
Home Based Care to HIV+ people 31 14 7 10 21 10
Spiritual Support to HIV+ people 23 10 4 9 14 9
n = numbers of facilities
Figure 1 Scale-up in HIV services and infant vaccinations,
2004-2007.
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adjusted for annual population growth, to estimate HIV
positive catchment populations. Proportions of HIV
positives (adults and children) with advanced disease
and requiring ART were derived from those reported by
Zambia for 2006 and 2007, projected back to 2005 and
2004 [18].
An ART pilot had been launched in Lusaka in 2002
by the Ministry of Health in two large hospitals, but cli-
ent load and coverage only began to increase signifi-
cantly in 2004 with the support of the Global Fund and
PEPFAR [16]. Scale-up in ART numbers and coverage
levels started in earnest in Kabwe in 2005 and in rural
Mumbwa in 2006 (Table 2). ART coverage percentages
are likely to be an over-estimate of population coverage
- Zambia reported national ART coverage at 33% for
2006 and 50% for 2007. The most plausible reason for
higher coverage levels in our study is that some of
those in need of ART were likely to have come from
other catchment areas to visit the ART-providing facil-
ities included in this analysis. ART scale-up in Lusaka
from 2002 is likely to have attracted some of those who
knew or suspected they needed ART. Total numbers
and coverage percentages for Lusaka and the three dis-
tricts combined are very similar, reflecting the contribu-
tion of the much larger population of ART clients in
Lusaka.
In the 16 facilities providing PMTCT for which there
were complete data across 2004-07 (Figure 1), the num-
bers of pregnant women attending for antenatal care
who received a HIV test rose from 14,541 (2004) to
26,066 (2007). A similar rolling-out pattern to that of
ART was seen. By 2004, 74% of pregnant women in
PMTCT-providing facilities in Lusaka were already
being tested, whereas in the six PMTCT facilities in
rural Mumbwa, testing only began to rise in 2006 where
it reached 36%, up from 3% in 2005, and quickly
r e a c h e d8 9 %b y2 0 0 7 .A g a i n ,h e a l t h -( A R T - )s e e k i n g
behaviour, where clients came from other catchment
areas, may have contributed to high coverage levels at
these facilities. Figure 2 illustrates PMTCT programme
trends in facilities with complete data for HIV testing
(16 facilities), test results (16 facilities) and treatment
(15 facilities). The percentage of antenatal clinic regis-
trants who received a HIV test in these facilities rose
from 70% in 2004 to 101% (100.6%) in 2007; the propor-
tion of pregnant women who tested positive fell from
24% to 20%, and close to 100% (97.8%) of HIV test posi-
tive pregnant women were reported to have received
antiretroviral treatment to prevent PMTCT.
The aim of this paper is to illustrate how non-HIV
service delivery and population coverage were perform-
ing in districts where there was rapid scaling up in the
delivery and coverage of HIV services. Figure 2 also
includes Reproductive Health Service coverage 2004-07,
calculated as the percentage of women of child-bearing
age (WCA) (15-49 years) registered for antenatal care
(ANC) and family planning (FP). Data on total numbers
of antenatal visits were available, but health
Table 2 ART coverage (those in need of ART) by district
location, 2004-07
Location Year Numbers of
facilities
Patients in need
of ART
Patients
receiving ART
Lusaka 2004 8 22315 5018 (22.5%)
2005 8 23962 12898 (53.8%)
2006 8 25711 19178 (74.6%)
2007 8 27461 20577 (74.9%)
2007* 10 36367 23549 (64.8%)
Kabwe 2004 4 2041 0 (0.0%)
2005 4 2153 215 (10.0%)
2006 4 2260 2734 (121.0%)
2007 4 2360 2005 (85.0%)
2007* 4 2360 2005 (85.0%)
Mumbwa 2004 4 504 0 (0.0%)
2005 4 542 0 (10.0%)
2006 4 580 35 (6.0%)
2007 4 612 229 (37.4%)
2007* 4 612 229 (37.4%)
Total 2004 16 24861 5018 (20.2%)
2005 16 26657 13113 (49.2%)
2006 16 28551 21947 (76.9%)
2007 16 30433 22811 (75.0%)
2007* 18 39340 25783 (65.5%)
* Note: 16 facilities reported continuous data across 2004-07 and a further
two reported only in 2007.
Figure 2 PMTCT and reproductive health coverage, 2004-2007.
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did not provide data on the numbers of women who
completed four antenatal care visits; nor on numbers of
family planning visits and adherence. Catchment popu-
lation sizes based on census estimates and adjusted
annually for population growth were used to calculate
the target population. Antenatal client numbers
increased steadily and coverage levels for both services
were maintained across all 29 facilities that reported
data consistently across the four years.
Target population sizes for immunisations were the
number of children under one year of age in each health
facility’s catchment population, adjusted for population
g r o w t h .T h i sw a saf i g u r er o u t i n e l yr e p o r t e db yt h e
DHMT. Overall, DPT3 coverage rates increased steadily,
year-on-year, from 73% (2004) to 91% (2007) and with-
out large fluctuations, supporting the hypothesis of an
effective immunisation programme. Between 2004 and
2007, BCG coverage rates rose from 112% to 117%. The
most likely explanation for BCG coverage rates greater
than 100% is that BCG is given soon after birth of the
child, usually at the first post-natal checkup visit. An
unknown number of women are likely to have travelled
from other catchment areas into ones with a health
facility with full mother and child health services includ-
ing delivery services, exceeding the target group sizes
for those catchment areas.
The major limitation of immunisation data, which is
considered further in the Discussion, is that they are
based on administrative data, i.e. antigens recorded as
delivered by health workers, and not usually (or in this
case) based on coverage surveys of children [19]. Figures
1 and 2 illustrate a consistent upward trend in the num-
ber of clients or client episodes for a range of core HIV
and non-HIV related mother and child health services;
steady (PMTCT) or rapid (ART) increases in HIV ser-
vice population coverage; and evidence that reproductive
and child health population programme coverage levels
were sustained or increased slightly. However, the ques-
tion posed is: were these upward trends in HIV and
non-HIV services happening in the same facilities?
Table 3 reports Spearman rank intrafacility correla-
tions in service trends between HIV and non-HIV ser-
vices within the same facilities for a three year period:
2005 to 2007 inclusive. Percentage changes (increases or
decreases) in numbers of clients/service episodes were
calculated for each facility and Spearman rank correla-
tions were measured, comparing pairs of services within
each facility, to obtain summary measures of trend
correlations (positive or negative) for each pair of ser-
vices. Complete data were available on pairs of services,
2005-07, for between nine and twelve facilities. Compar-
isons between each of three HIV service trends (ART,
PMTCT and VCT) and four non-HIV service trends
(antenatal care, family planning, BCG and DPT3) pro-
duced 12 pairs of association (Table 3): nine showed
positive correlations, two were negative and one was
zero. Pairs of services where the Spearman rank correla-
tion was greater than 0.3 are illustrated in scatter graphs
in Figure 3. Plausible reasons for correlations are dis-
cussed later.
The strongest rank correlation was between ART and
family planning (Spearman rank coefficient = 0.83) in
nine facilities that reported both sets of data between
2005 and 2007. This means that health facilities where
the number of ART clients increased generally also
experienced an increase in the numbers of family plan-
ning clients; and facilities that had greater increases in
one service (ART) usually had greater increases in the
other (family planning). It also illustrates that facilities
Table 3 Intrafacility correlations in service trends between HIV and non-HIV services, 2005-07 (Spearman rank
correlations)
Facilities reporting
clients for two services
Number of
facilities
Spearman Rank Correlation
(positive unless otherwise stated)
ART and Antenatal Clinic 9 0.22
ART and Family Planning Clinic 9 0.83
ART and DPT 3 vaccine 9 0.00
ART and BCG vaccine 9 0.27
PMTCT and Antenatal Clinic 12 0.50
PMTCT and Family Planning Clinic 12 0.33
PMTCT and DPT 3 vaccine 12 - 0.11
PMTCT and BCG vaccine 12 0.14
VCT and Antenatal Clinic 11 0.12
VCT and Family Planning Clinic 11 0.38
VCT and DPT 3 vaccine 11 0.15
VCT and BCG vaccine 11 - 0.30
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0 7 ,w e r em o r el i k e l yt os e eaf a l li nn u m b e r so ff a m i l y
planning clients. Family planning trends in seven of the
non-ART providing facilities showed an increase
between 2004 and 2007. Overall, family planning client
numbers, which peaked in 2005, had fallen slightly by
2007 (Figure 2).
Positive associations between ART and antenatal clinic
registrants (0.22) and between ART and BCG vaccina-
tions (0.27) were weaker; and the correlation between
ART and DPT3 was zero. Excluding one facility with a
greater than 500% increase in the number of ART cli-
ents increased the latter correlation to 0.17; and a
further exclusion of a facility with an upward DPT3
trend of >180% increased the correlation coefficient to
0.75. Such changes illustrate the effects of small sample
sizes in the analysis and the sensitivity of the analysis to
the effects of changes in just one or two facilities. Gen-
erally, removal of facilities with more extreme trends
resulted in tighter correlations.
Positive correlations between trends in PMTCT and
other reproductive health services were expected and
were found (12 facilities in the analysis). There was a
positive correlation between PMTCT and ANC atten-
dance of 0.5 (Table 3). When one facility with an
upward trend of 700% was excluded from the analysis,
Figure 3 Correlations of changes in services, 2005-2007.
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Page 6 of 12the correlation rose to 0.78. PMTCT and family plan-
ning client trends were also positively correlated (0.33)
and there was a fairly strong positive correlation
between VCT and family planning (0.38). Data were
also collected on a range of other non-HIV services and
support services, including a range of laboratory tests.
Small numbers reduced the numbers of facilities avail-
able for trend analyses: for example, only district hospi-
tals, larger clinics and large NGO facilities were
providing laboratory services.
An assessment of stock maintenance for drugs and
commodities yielded some relevant results (Table 4).
Only 7% of facilities that stocked antiretroviral drugs
(ARVs) reported stock-outs in the previous 12 months:
6% for first line ARVs (among 31 facilities stocking
them) and 8% for second line (from 24 facilities). Stock-
outs of important drugs or commodities for non-HIV
priorities were significantly more frequent. These
included Coartem - the new first line drug to treat
Malaria (stock-outs had occurred in 50% of facilities)
and Co-trimoxazole - a routine antibiotic (stock-outs in
28% of facilities) - both of which were significantly more
common (p. <0.05) than were stock-outs of first and
second line ARVs. Stock-outs of important commodities
for the management of labour and delivery of infants -
Oxytocin to accelerate labour (26%) and ergometrine for
the management of postpartum haemorrhage (24%) -
were also more common than for first line ARVs (p. <
0.05). Only two of four facilities that reported ARV
stock-outs had experienced these for more than one
m o n t h .E l e v e no f1 9( 5 8 % )s t o c k - o u t so fC o a r t e mw e r e
for greater than one month.
Discussion
For too long, debates around the positive versus nega-
tive synergies and systemwide effects of HIV funding on
other programme and disease control priorities, espe-
cially in sub-Saharan Africa with its multiple burdens of
disease and fragile health systems, have ignored the
need for evidence, or have relied on key informant inter-
view studies [20]. These are valid methods, which we
have used, but are not the method of choice for quanti-
fying and comparing client numbers and trends for HIV
and non-HIV priority services. They are vulnerable to
bias, or at least wishful thinking, in the hotly contested
arena where evidence of positive or negative effects of
earmarked funding for specific diseases could influence
donors’ funding decisions. This paper does not provide
the answer to the question: is successful scale-up of HIV
services, which this paper confirms is happening in
Zambia, having a beneficial or detrimental effect on
other priority services. However, it does provide an
answer, based on a small sample of facilities; and - more
importantly - it provides an evaluation approach that
needs to be replicated in larger samples and preferably
on a national scale.
In facilities that had begun to rapidly scale-up HIV
services and continued to provide other priority mother
and child health services, the findings provide some sup-
port for the view that the former was having positive
effects on the latter, at least with respect to antenatal
care and family planning. How reliable is such evidence
and how much weight can be placed on it? Firstly, there
is a plausibility to it, or at least plausible hypotheses can
be drawn from the findings, which need to be explored
or tested. For example, there are obvious reciprocal con-
nections, for example between PMTCT and antenatal
care: one would expect (or at least want) that a facility
that is offering PMTCT, as part of its antenatal care,
would attract more pregnant women to attend for
antenatal care. Also, antenatal care of women who come
to a health facility when pregnant, is the main route to
PMTCT. The linkage between PMTCT and antenatal
care in Zambia has been demonstrated by Potter et al
(2008) [15], who demonstrated improved quality of
antenatal care in Lusaka facilities delivering PMTCT, as
evidenced by trends in documented syphilis screening in
pregnant women.
The strong positive associations of family planning cli-
ent numbers with PMTCT, ART and VCT client num-
bers are interesting. Integrated services for family
planning and HIV have been promoted over recent
years [21-23]. A systematic review, which mainly
focused on project-type interventions that sought to link
Table 4 Drugs and commodities normally stocked and
stock-outs in 2007
Drug/commodity Normally
stocked
Stock-out
in last
12 months
Stock out
* greater
than 1 month
ARV First-line** 31 2 (6.4%) 1 (50.0%)
ARV Second-line 24 2 (8.3%) 1 (50.0%)
Lamivudine 25 2 (8%) 0 (0.0%)
Rifampicin 33 7 (21.2%) * 3 (42.9%)
Cotrimoxazole 39 11 (28.2%) 4 (36.4%)
Coartem 38 19 (50%) * 11 (57.9%)
Male condom 37 6 (16.2%) * 2 (33.3%)
Iron Tablets 39 8 (20.5%) 3 (37.5%)
Rehydration salts 38 7 (18.4%) * 1 (14.3%)
Ergometrine 33 8 (24.2%) 4 (50.0%)
Oxytocin 23 6 (26.1%) * 2 (33.3%)
IV giving test 37 6 (16.2%) * 4 (66.7%)
Syringes 38 10 (26.3%) * 3 (30%)
* Missing responses account for columns B and C not adding up to column A.
** Facility mapping identified 29 facilities providing ART. The pharmacy facility
survey identifed a further 2 facilities stocking ARVs.
Brugha et al. BMC Public Health 2010, 10:540
http://www.biomedcentral.com/1471-2458/10/540
Page 7 of 12family planning with VCT services, concluded that the
evidence demonstrated the feasibility and effectiveness
of integration [24]. The linkages are plausible and con-
sistent with a move to provide integrated services to
meet women’s reproductive health needs, which dates
back at least to the 1994 Cairo Conference on Popula-
tion and Development.
We did not explore internal referral processes in these
facilities, although others have reported on a programme
that used antenatal care as an opportunity to initiate
eligible women on ART [25]. One would expect (or at
least want) that women who register for ART, perhaps
postnatally on completion of PMTCT, would be referred
to register for family planning services. This was the
strongest correlation (Spearman coefficient = 0.83) in
our analysis. One study estimated that the impact of
PMTCT services would double in 14 high prevalence
countries, by integrating family planning and PMTCT
services [26]. A somewhat surprising finding in our ana-
lysis, which needs to be assessed in larger sample size
quantitative analyses and explored in future explanatory
mixed methods research (see Conclusion), was that the
positive rank correlations of family planning client num-
bers with HIV service trends was partly due to down-
ward trends in both sets of services in a minority of
facilities and that numbers of family planning clients
were increasing in facilities not delivering ART.
The significance of the study findings is that a popula-
tion-based approach was used to select health facilities
for the study. We did not select project facilities where
a special primary health care approach was being used
to ensure non-HIV priorities benefited in tandem with
HIV service scale up. Nor was the study restricted to
‘research facilities’, although journal articles based on
data from Lusaka indicate that a lot of ART and
PMTCT research was going on in facilities that were
included in our study [15,25]. Three of 11 PMTCT -
antenatal care facility pairings in our study were from
f a c i l i t i e so u t s i d eo fL u s a k a ,a sw e r e4o f1 2P M T C T -
family planning facility pairings. While enhanced inte-
gration may have been a programme effect, one might
also expect the opposite where a programme supported
by PEPFAR funding would prioritise HIV services at the
expense of family planning services. A contextual factor
that would help explain integrated services and positive
correlations is Zambia’s policy of “integration and scal-
ing-up of the Prevention of Mother-to-Child Transmis-
sion of HIV and AIDS strategy into maternal and child
health services” as a strategy to reach Millennium Devel-
opment Goals (MDG) 4 and 5 [27].
There are some caveats or limitations to this study,
before considering its broader significance. Firstly, it is
based on a sample of three districts, though because of
the inclusion of the capital city and another urban
setting where early HIV scale-up was taking place, it did
c a p t u r eah i g hp r o p o r t i o no fn a t i o n a lA R Ts c a l eu p
between 2004 and 2007. Also, only facilities that were
identified in a May 2008 mapping exercise as providing
ART were included, which would have excluded facil-
ities that began to deliver ART subsequently [15].
Therefore representativeness cannot be assumed. How-
ever, it is the internal validity that is important, i.e. the
findings do illustrate what was happening within the
surveyed facilities.
The subsets of facilities where data were available to
enable correlations to be measured resulted in small
numbers (between 9 and 12 pairs for each analysis - see
Table 3). The main reason for this was that the study
aim was to demonstrate trends over time and the initia-
tion of ART and PMTCT in 2006 in rural Mumbwa dis-
trict meant that all of these facilities were excluded from
the 2005-07 trend analysis. Consequently, Lusaka con-
tributed most of the facilities to the analyses shown in
Table 3 and Figure 3, ranging from eight of nine (for
family planning and ART) to six of eleven facilities (for
VCT and family planning). Hence, any hypotheses and
assumptions around positive effects of HIV scale-up on
other services have quite limited generalisability. Studies
that utilise this approach need to be replicated with lar-
ger numbers and representative samples of facilities,
capturing later years when HIV service roll-out has
extended to more districts.
Secondly, routine health information collected by
health workers has several limitations, though we would
contend that analysis of such data is more important in
the long run than conducting special surveys. Recording
errors are possible at all stages from initial completion
of reporting forms and client registers through to
reporting at the national level, or as part of a research
study [28,29]. Such problems have been identified in
Zambia [30] and in our study four facilities reported dif-
ferent returns for numbers of clients registered for
antenatal care and six for family planning, when com-
paring two sources of data - facility record reviews and
district office data. Such errors reflect the lack of atten-
tion there has been to health facility data and reporting,
while acknowledging that steps to improve routine data
collection have been included in Zambia’s 2009-2015
national information strategy [31].
Immunisation data returns are normally considered to
be inherently inferior to population-based data, in that
the former are based on numbers and types of vaccine
antigens delivered, rather than on numbers and ages of
children immunised. Coverage rates are then based on
estimates of the target population, rather than on actual
children identified in household surveys. The denomina-
tors (catchment populations) can be an underestimate
of the size of the target group because children from
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may travel to facilities that offer such services. This can
result in numerators (numbers of children immunised)
that exceed the denominators (catchment target popula-
tion sizes), as was found in this study. However, despite
difficulties in interpretation that are commonly found
when analysing routine vaccination data returns, these
findings provide evidence that district immunisation
programmes have continued to be delivered at a sus-
tained level to the populations in the catchment areas of
the three districts where HIV/AIDS scale up has been
taking place. Intra-facility analysis did not demonstrate
any consistent correlation between HIV and immunisa-
tion service trends.
The primary aim of the studies conducted under the
umbrella of the Global HIV/AIDS Initiative Network
(GHIN) was to assess the wider systems’ effects of global
HIV funding. The GHIN researchers recognised from
the start the importance of measuring and acknowled-
ging the primary aim and effects of the GHIs, which
was to scale-up and reach more people with the HIV
interventions that they needed. The findings on HIV
scale up (Tables 1 and 2, and Figures 1 and 2) corre-
spond with and confirm those reported by other
researchers in Zambia. Our PMTCT data showed a
similar trend to that of Stringer et al (2006) [16], which
reported a decline in HIV positivity from 25.7% to
21.8% among pregnant women who were tested. This
was not surprising, given that there would have been
overlap in the data sources in Lusaka, which provided
81.4% of the pregnant women that were HIV tested in
our study.
One of the GHIN objectives was also to assess access
and equity effects, for example to assess if rural dwellers
were also benefiting from interventions that were first
rolled out in capital cities and other urban centres. In
that respect, while Mumbwa rural district is not as diffi-
cult to reach as many parts of the Northern Province of
Zambia, the findings show that once significant scale-up
had started in Mumbwa (PMTCT in 2006 and ART in
2007) client numbers and coverage rose rapidly.
The wider significance of the findings in this study is
that they illustrate the potential to derive useful evi-
dence - for district as well as national programme man-
agers - from routinely collected health facility data. Two
approaches to collecting evidence on the performance of
health systems have dominated in the last 10 years, one
top-down and the other bottom- (or population-) up:
the Health Metrics Network has carried out valuable
work on the development of indicators and the Institute
of Health Metrics has demonstrated the power of collat-
ing data and comparing performance across countries
and regions [29,32]. Countries, such as Zambia, have
followed this lead and have focused much of their
efforts on aggregating data nationally and reporting to
international fora such as the UNGASS [18].
The second approach has been bottom-up, where con-
siderable efforts and funding has been allocated by
donors to conducting household surveys, which - unlike
health facility data - provide evidence of unmet need
and health seeking behaviour, as well some evidence of
services accessed [33,34]. However, as has been recog-
nised by some commentators [30,35], insufficient atten-
tion has been paid to what is happening in the middle,
that is at health facilities where disaggregated data need
to be collected on performance, so as to identify good
and poor performers and take action. In our initial 2007
survey, much effort was expended on collecting data on
routine services (family planning, immunisations,
antenatal care) directly from health facilities. Not
uncommonly, data were missing because facilities had
made data returns to the district office but had not
retained copies at the health facility. This is sympto-
matic of what is fundamentally wrong about how health
information systems (HIS) work in sub-Saharan Africa;
or rather how they sometimes work for higher level
planners (national, provincial and sometimes district),
and do not work where they should work, which is at
the health facility level.
In the 2008 survey we found that most of the routine
non-HIV service data was available in disaggregated for-
mats (disaggregated to individual health facilities) at dis-
trict health offices. The non-HIV priority service data
used in the paper were part of a functioning - if
neglected - health information system. The senior
researchers who were supervising the field work found
little or no evidence that data were being analysed and
acted upon at the facility, or even at the district level.
One explanation for the non-use of data is the multiple
burden of data collection at facility and district level in
Zambia, due to parallel health information systems
established to meet the information needs of global
initiatives [36].
This paper demonstrates the feasibility of obtaining and
analysing routinely collected data to illustrate the perfor-
mance of non-HIV priority services in facilities where
HIV services are scaling-up. Some findings should con-
cern programme managers who have overall responsbility
for the health services system. The reported availability in
the previous 12 months of essential drugs for national
priorities - malaria, bacterial infections and management
of normal labor and obstetrical emergencies - was signifi-
cantly poorer than for ARVs. While stock-outs were
more frequent in the rural district, they were also
(surprisingly) common in Lusaka. This suggests that,
while AIDS funding can strengthen pharmaceutical man-
agement [13], non-HIV drug and commodity manage-
ment had been less reliable in the previous year than it
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cannot infer any association between HIV and non-HIV
pharmaceutical management.
The findings demonstrate upward trends in client
numbers for non-HIV maternal and child health pro-
grammes, in three districts where HIV services were
scaling-up. The analysis also demonstrates scale-up in
reproductive health service client numbers (family plan-
ning and antenatal care), generally in the same facilities
where HIV services were scaling up; and the rank corre-
lation supports the interpretation that this was an aetio-
logical link. However, the stated caveats mean that those
who are seeking definitive evidence to conclude that
investments in HIV benefit other service priorities
should await more conclusive evidence. Interestingly,
district childhood immunisations increased overall, but
not in the facility catchment areas where HIV scale-up
was happening.
Conclusions
This paper has begun to answer some of the research
questions raised by Rabkin et al (2009) [14], not only
with respect to service linkages but also about the
potential for using routine data for better evidence.
What the paper does not do is to explain the trends.
National planners can be encouraged about evidence
that comprehensive reproductive health service delivery
- which is part of Zambia’s Vision 2030 strategy - boosts
target population coverage. Researchers can justifiably
interpret the findings in Lusaka as a reflection of the
positive spin-offs from research [15], which may also be
a Hawthorne Effect, whereby health workers who were
being researched were motivated to increase their per-
formance. However such interpretations are based on
conjecture.
This study has helped to place some of the pieces of
the jigsaw puzzle that comprises the health systems’
effects of HIV funding. What is needed now is a replica-
tion of these intrafacility correlation analyses across a
larger and more representative sample of facilities,
including ones that are less subject to research, and
across other countries. More important, though, is the
need for explanatory studies that move beyond correla-
tion studies to analyse the processes within facilities to
understand and explain such trends. Sequential, expla-
natory mixed methods studies are needed, where facility
staff are shown trend summaries and asked to provide
explanations; and where patients/clients are interviewed,
so as to understand how the availability and configura-
tion of different services influence their health seeking
behaviour. It is at the health facility level that most
national disease control and population health targets
will be achieved, or not.
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